Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial

被引：0

作者：

Nils Venhoff

Wolfgang A. Schmidt

Peter Lamprecht

Hans-Peter Tony

Christine App

Christian Sieder

Carolin Legeler

Claudia Jentzsch

Jens Thiel

机构：

[1] Klinik für Rheumatologie und Klinische Immunologie,Department Innere Medizin

[2] Vaskulitiszentrum Freiburg,Department of Immunology, Hepatology & Dermatology

[3] Universitätsklinikum Freiburg,undefined

[4] Immanuel Krankenhaus Berlin,undefined

[5] Klinik für Innere Medizin,undefined

[6] Abteilung Rheumatologie und Klinische Immunologie in Berlin-Buch,undefined

[7] Universität zu Lübeck,undefined

[8] Klinik für Rheumatologie und klinische Immunologie,undefined

[9] Medizinische Klinik II,undefined

[10] Universitätsklinik,undefined

[11] Rheumatology/Immunology,undefined

[12] Novartis Pharma GmbH,undefined

[13] Novartis Pharma AG,undefined

来源：

Trials | / 22卷

关键词：

Giant cell arteritis; Secukinumab; Phase II trial; Placebo; Double-blind;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
Liang Dai
Linda L. D. Zhong
Yan Cao
Wei Chen
Ying Cheng
Xiu-Fang Lin
Zhao-Xiang Bian
Ai-Ping Lu
Trials, 17
[22] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
Qi Chen
Zi Wang
Jicheng Lv
Lijun Liu
Hang Li
Weiwei Sun
Yanhong Huo
Yingbo Guo
Cun Shen
Shichao Li
Zhenjie Chen
Jingwei Zhou
Trials, 23
[23] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
Dai, Liang
Zhong, Linda L. D.
Cao, Yan
Chen, Wei
Cheng, Ying
Lin, Xiu-Fang
Bian, Zhao-Xiang
Lu, Ai-Ping
TRIALS, 2016, 17
[24] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
Biton, V
Rosenfeld, W
Schachter, S
Perdomo, C
Arroyo, S
ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
[25] Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Reetz, Kathrin
Hilgers, Ralf-Dieter
Isfort, Susanne
Dohmen, Marc
Didszun, Claire
Fedosov, Kathrin
Kistermann, Jennifer
Mariotti, Caterina
Durr, Alexandra
Boesch, Sylvia A.
Klopstock, Thomas
Garrido, Francisco Javier Rodriguez de Rivera
Schoels, Ludger
Klockgether, Thomas
Pandolfo, Massimo
Korinthenberg, Rudolf
Lavin, Philip
Molenberghs, Geert
Libri, Vincenzo
Giunti, Paola
Festenstein, Richard
Schulz, Joerg B.
NEUROLOGICAL RESEARCH AND PRACTICE, 2019, 1 (01):
[26] A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
Hoffman, GS
Cid, MC
Hellman, DB
Guillevin, L
Stone, JH
Schousboe, J
Cohen, P
Calabrese, LH
Dickler, H
Merkel, PA
Fortin, P
Flynn, JA
Locker, GA
Easley, KA
Schned, E
Hunder, GG
Sneller, MC
Tuggle, C
Swanson, H
Hernández-Rodríguez, J
Lopez-Soto, A
Bork, D
Hoffman, DB
Kalunian, K
Klashman, D
Wilke, WS
Scheetz, RJ
Mandell, BF
Fessler, BJ
Kosmorsky, G
Prayson, R
Luqmani, RA
Nuki, G
McRorie, E
Sherrer, Y
Baca, S
Walsh, B
Ferland, D
Soubrier, M
Choi, HK
Gross, W
Segal, AM
Ludivico, C
Puechal, X
ARTHRITIS AND RHEUMATISM, 2002, 46 (05): : 1309 - 1318
[27] Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Kathrin Reetz
Ralf-Dieter Hilgers
Susanne Isfort
Marc Dohmen
Claire Didszun
Kathrin Fedosov
Jennifer Kistermann
Caterina Mariotti
Alexandra Durr
Sylvia Boesch
Thomas Klopstock
Francisco Javier Rodríguez de Rivera Garrido
Ludger Schöls
Thomas Klockgether
Massimo Pandolfo
Rudolf Korinthenberg
Philip Lavin
Geert Molenberghs
Vincenzo Libri
Paola Giunti
Richard Festenstein
Jörg B. Schulz
Neurological Research and Practice, 1
[28] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
Lee, Su Won
Choi, Jin Kwan
Lyu, Yee Ran
Yang, Won Kyung
Kim, Seung Hyung
Kim, Je Hyun
Kim, Si Yeon
Kang, Weechang
Jung, In Chul
Lee, Beom Joon
Choi, Jun Yong
Kim, Taesoo
Park, Yang Chun
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
[29] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
Lee, Su Won
Choi, Jin Kwan
Lyu, Yee Ran
Yang, Won Kyung
Kim, Seung Hyung
Kim, Je Hyun
Kim, Si Yeon
Kang, Weechang
Jung, In Chul
Lee, Beom Joon
Choi, Jun Yong
Kim, Taesoo
Park, Yang Chun
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
[30] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
Lee, Su Won
Choi, Jin Kwan
Lyu, Yee Ran
Yang, Won Kyung
Kim, Seung Hyung
Kim, Je Hyun
Kim, Si Yeon
Kang, Weechang
Jung, In Chul
Lee, Beom Joon
Choi, Jun Yong
Kim, Taesoo
Park, Yang Chun
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022

← 1 2 3 4 5 →